Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

Summary

The purpose of the study is to compare the efficacy and safety of benralizumab versus placebo and to compare benralizumab dosing regimens during extension period.

Timeline

Start

2020-11-12

Primary completion

2022-04-25

Completion

2022-09-13

Drugs

Indications